Numinus Wellness (LKYSF) News Today → Bible Shocker: Have You Seen Elon Musk’s Miracle? (From InvestorPlace) (Ad) Free LKYSF Stock Alerts $0.05 0.00 (0.00%) (As of 05/17/2024 ET) Add Compare Share Share HeadlinesStock AnalysisChartHeadlinesStock AnalysisChartHeadlines All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative January 20, 2024 | benzinga.comNuminus Wellness Stock (OTC:NUMIF), Analyst Ratings, Price Targets, PredictionsJanuary 19, 2024 | benzinga.comNuminus Wellness Stock (OTC:NUMIF) Dividends: History, Yield and DatesJanuary 8, 2024 | theglobeandmail.comClosing Bell: Numinus Wellness Inc up on Thursday (NUMI)January 8, 2024 | theglobeandmail.comClosing Bell: Numinus Wellness Inc up on Friday (NUMI)January 6, 2024 | theglobeandmail.comClosing Bell: Numinus Wellness Inc up on Tuesday (NUMI)December 17, 2023 | investing.comNuminus Wellness Inc (NUMI) Earnings Dates & ReportsNovember 6, 2023 | theglobeandmail.comClosing Bell: Numinus Wellness Inc up on Wednesday (NUMI)November 5, 2023 | morningstar.comNuminus Wellness Inc Ordinary Shares NUMIFSeptember 26, 2023 | proactiveinvestors.comNuminus Wellness announces at-the-market equity offering programSeptember 19, 2023 | proactiveinvestors.comNuminus Wellness hails study results as milestone for psychedelics industrySeptember 19, 2023 | proactiveinvestors.comNuminus Wellness hails MAPS study results as significant milestone for the psychedelics industrySeptember 19, 2023 | proactiveinvestors.comNuminus Wellness takes strategic measures to accelerate toward...June 22, 2023 | proactiveinvestors.comNuminus Wellness announces partnership with HealingMapsJune 5, 2023 | proactiveinvestors.comNuminus Wellness designated as a top research site for MindMed studyMay 30, 2023 | proactiveinvestors.comNuminus Wellness announces largest-of-its-kind study of psilocybin therapy to treat depressionMay 25, 2023 | proactiveinvestors.comNuminus Wellness positioned to lead in MDMA-assisted therapy as FDA approval nearsApril 11, 2023 | proactiveinvestors.comNuminus Wellness launches new clinic licensing platform to accelerate expansionMarch 27, 2023 | proactiveinvestors.comNuminus launches practitioner Certification Pathway -a complete psychedelic-assisted therapy training programMarch 7, 2023 | prnewswire.comNuminus Wellness Inc. Executives to Present on Panel at Upcoming South by Southwest ConferenceFebruary 18, 2023 | theglobeandmail.comClosing Bell: Numinus Wellness Inc flat on Thursday (NUMI)February 17, 2023 | proactiveinvestors.comNuminus Wellness expands research capabilities with new Phoenix siteJanuary 17, 2023 | finance.yahoo.comNuminus Wellness Inc. (NUMIF)January 17, 2023 | proactiveinvestors.comNuminus Wellness reports surge in 1Q revenue as Novamind acquisition beds inJanuary 17, 2023 | proactiveinvestors.comNuminus Wellness reports surge in 1Q revenue as Novamind acquisition beds downDecember 16, 2022 | proactiveinvestors.comProactive research analyst on Numinus Wellness' annual resultsDecember 14, 2022 | proactiveinvestors.comNuminus Wellness eyes Nasdaq listing and sees profitability by end-2024 according to Water TowerDecember 8, 2022 | proactiveinvestors.comNuminus submits clinical trial application to Health Canada for experiential Psilocybin-Assisted Therapy training researchDecember 1, 2022 | proactiveinvestors.comNuminus Wellness 4Q results highlighted the impact of its Novamind acquisition, notes Water Tower ResearchNovember 29, 2022 | benzinga.comNuminus Wellness Inc.'s Q4 And Fiscal 2022 Report Shows Revenues Grew 464% To $4.2MNovember 1, 2022 | proactiveinvestors.comNuminus Wellness unveils revamped podcast series with additional hosts and expanded topicsOctober 30, 2022 | finance.yahoo.comNuminus Launches Psychedelic-Assisted Therapy for Chronic and Serious Medical IllnessOctober 28, 2022 | proactiveinvestors.comNuminus Wellness launches Ketamine for Chronic and Serious Medical Illness ProgramOctober 7, 2022 | finance.yahoo.comNuminus Develops Mushroom Tea for Use in Psychedelic ResearchOctober 6, 2022 | benzinga.comMushroom Tea For Use In Psychedelic Research Developed By Numinus WellnessSeptember 29, 2022 | proactiveinvestors.comNuminus Wellness positioned to benefit from multi-billion psychedelic industry, analysts saySeptember 22, 2022 | proactiveinvestors.comNuminus Wellness announces opening of new clinic with expanded capacity in MontrealSeptember 19, 2022 | proactiveinvestors.comNuminus Wellness says its Toronto clinic now offering ketamine-assisted therapySeptember 13, 2022 | proactiveinvestors.comNuminus Wellness updates on integration of Novamind acquisitionJune 23, 2022 | ca.proactiveinvestors.comNuminus Wellness says piloting program to offer ketamine-assisted psychotherapy as a health benefit for eligible employeesJune 23, 2022 | proactiveinvestors.comNuminus Wellness piloting program to offer ketamine-assisted psychotherapy as a health benefit for eligible employeesJune 22, 2022 | ca.proactiveinvestors.comNuminus applies for international patent for psychedelics production processJune 22, 2022 | benzinga.comNuminus Submits New Patent Application To UN Agency For Psilocybe & Novel Fungi SpeciesJune 13, 2022 | ca.proactiveinvestors.comNuminus Wellness completes acquisition of Novamind; announces executive team expansionJune 9, 2022 | benzinga.comNew Acquisition: Novamind To Buy Common Shares Of Numinus Pending Canadian Supreme Court ApprovalJune 9, 2022 | ca.proactiveinvestors.comNuminus Wellness says shareholders have approved resolution in connection with the proposed acquisition of NovamindMay 16, 2022 | proactiveinvestors.comNuminus Wellness granted Health Canada approval for psychedelic-assisted therapy using psilocybin for patient with treatment-resistant depressionApril 12, 2022 | proactiveinvestors.comNuminus Wellness strikes deal to acquire US psychedelic healthcare company Novamind for C$26.2MMarch 30, 2022 | benzinga.comNuminus Administers MDMA To First Volunteer In Clinical Trial Sponsored By MAPSMarch 30, 2022 | proactiveinvestors.comNuminus Wellness completes first MDMA administration in PTSD trial sponsored by MAPSMarch 14, 2022 | proactiveinvestors.comNuminus Wellness says its research lab receives new biosecurity license for expansion Get Numinus Wellness News Delivered to You Automatically Sign up to receive the latest news and ratings for LKYSF and its competitors with MarketBeat's FREE daily newsletter. Email Address The ONE AI Stock to own now. (It’s not Nvidia.) (Ad)Don’t panic — you haven’t missed the boat on AI. In fact, it has barely launched. Sure, the early stages of this boom were big … But I believe the real wealth in AI has yet to be made … Click here to see the presentation now. LKYSF Media Mentions By Week LKYSF Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. LKYSF News Sentiment▼0.000.42▲Average Medical News Sentiment LKYSF News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. LKYSF Articles This Week▼00▲LKYSF Articles Average Week Get Numinus Wellness News Delivered to You Automatically Sign up to receive the latest news and ratings for LKYSF and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: TGIFF News FFNTF News ABSCF News ACONW News ACRHF News ACRDF News ADMT News ALEAF News AGNPF News ALBHF News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:LKYSF) was last updated on 5/19/2024 by MarketBeat.com Staff From Our PartnersBill Gates is all about this tiny $2 stockTimothy SykesCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingDems have chosen Biden replacement?Paradigm PressMan who spotted Apple at $1.49 says: “Buy These 6 AI Stocks.”InvestorPlaceForget Bitcoin: This $8 Stock Is the Next Big ThingBehind the Markets[URGENT] DO NOT Touch These AI Stocks!Weiss RatingsBuy this small stock before coming AI Tidal WaveChaikin AnalyticsShocking $16T Elon Musk Crypto LeakCrypto 101 Media Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Numinus Wellness Inc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
